Guggenheim says Cathie Wood-favorite Teladoc can jump more than 40%
Investment firm Guggenheim initiated coverage of Teladoc with a buy rating.
What's your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0